By Chris King •
Published: 05 Oct 2021 • 0:45
European Medicines Agency approves third shot of Pfizer vaccine.
THE European Medicines Agency (EMA) has approved the third booster shot of the Pfizer vaccine for all those between 18 and 55 years of age
The European Medicines Agency (EMA) has today, Monday, October 4, approved the administering of a third dose of the Pfizer vaccine to all those aged between 18 and 55. The decision to apply this has been left entirely in the hands of each country’s individual authorities.
This third shot would need to be given six months after the second one, though in the case of immunosuppressed people, then it can be injected at least 28 days after the second.
A decision was reached by this European body after they examined the results of Pfizer in clinical trials for adults aged 18 to 55 years, which they determined, “showed an increase in antibody levels when a booster dose is given approximately six months after the second”.
Adding, “Based on these data, the EMA Committee for Pharmaceutical Products for Human Use (CHMP) has concluded that a booster dose could be considered for people 18 years of age and older”.
Each member state of the EU has been left to make their own decision on this third dose of Pfizer, but the EMA has advised authorities to take into account the information provided by Pfizer, and also the possible “risks” of adverse effects that the body is investigating.
In a statement, the body explained, “At the national level, public health organisations may publish official recommendations on the use of booster doses, taking into account the information on emerging effectiveness, and limited safety data, in relation to the risk of coronary inflammation, and other very rare effects after the booster dose that are being carefully investigated”.
The United States and Israel have already decided on a third vaccine jab for their populations. But, in Spain, the experts who update the vaccination strategy are more focused on analyzing the evidence, in order to decide which specific groups should be revaccinated, than on giving a third dose to the general population.
Making the distinction between ‘additional dose’ and a ‘booster dose’ abundantly clear, the EMA stated that the former is for those who, due to having a weakened immune system – due to illness or age – have not achieved a level of protection against the coronavirus.
While the latter is for people who have experienced a normal effect of the vaccine, and whose level of protection can simply be reinforced after a while, as reported by 20minutos.es.
Thank you for reading, and don’t forget to check The Euro Weekly News for all your up-to-date local and international news stories.
Share this story
Subscribe to our Euro Weekly News alerts to get the latest stories into your inbox!
By signing up, you will create a Euro Weekly News account if you don't already have one. Review our
Originally from Wales, Chris spent years on the Costa del Sol before moving to the Algarve where he is a web reporter for The Euro Weekly News covering international and Spanish national news.
Got a news story you want to share? Then get in touch at email@example.com
Have you seen the state of Israel? Hospitals full of triple jabbed people…it´s a disaster. Thank goodness the Spanish agencies are showing some consideration before stuffing more poison into people whose systems have already been compromised
And what´s next? A jab every month or every week? The doctors and the companies already admit that these injections do not stop you from getting infected or passing it on, in fact there is considerable weight behind the argument that “vaccinated” people are more likely to pass on an infection………..of whatever it is……
None of this works, not that it was necessary in the first place.
Comments are closed.
Download our media pack in either English or Spanish.